KEY TAKEAWAY: The results of an exit survey on two top pharma websites had terrible news for the marketing team. Less than 10% of visitors to the site were going to ask their doctor for/about the medication, and the vast majority (84%) said the website failed to answer their questions about the drug or health condition.
Continue reading
KEY TAKEAWAY: The public sees profits made by pharmaceutical companies as a major factor contributing to the price of prescription drugs. Majorities of the public trust pharmaceutical companies (either “a lot” or “somewhat”) to be good stewards in terms of developing new effective drugs (71 percent), and offering reliable information to consumers about drug safety and side effects (65 percent) as well as drug efficacy (61 percent).
Continue reading
KEY TAKEAWAY: As it appears that the criticism of drug prices from politicians and the President has quieted down, companies are more aggressively and broadly pursuing drug price increases again.
Continue reading
KEY TAKEAWAY: Trump’s threat to issue an executive order on drug pricing, if issued, will be overturned as “unconstitutional”. There are no quick fixes to rein on excessive healthcare costs. They can only be addressed through a thorough bipartisan review of the way our healthcare system function.
Continue reading
KEY TAKEAWAY: Anger over healthcare costs is not going to lead to workable solutions yet the media is generating anger via headlines that fail to adequately communicate the complexity and greed that has become the American healthcare system.
Continue reading
KEY TAKEAWAY: The current economic cost of unpaid family care is about $67 billion and includes reduced work hours and foregone earnings for Americans 20 to 64 years old who take time off from their jobs to help a loved one manage serious medical issues. This is based on population demographics and wage data from 2013.
Continue readingKEY TAKEAWAY: So far in 2019, more than 3,400 drugs have boosted their prices, a 17% increase compared with the roughly 2,900 drug price increases at the same time in 2018, according to a new analysis by Rx Saving Solutions, a consultant to health plans and employers. The average price hike for those 3,400 drugs stands at 10.5% or about 5 times the rate of inflation, the study found.
Continue reading
